Blood Eosinophil–directed Management of Airway Disease. The Past, Present, and Future

por Pavord, Ian D.
Publicado 2020

Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease

por Bush, Andrew, Pavord, Ian D.
Publicado 2021

Reply to: Challenging the paradigm

por Bush, Andrew, Pavord, Ian D.
Publicado 2022

Living without eosinophils: evidence from mouse and man

por Jackson, David J., Pavord, Ian D.
Publicado 2023

Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight

por Howell, Imran, Howell, Aleksandra, Pavord, Ian D.
Publicado 2023

Fractional exhaled nitric oxide (FeNO): the future of asthma care?

por Wang, Kay, Stonham, Carol, Rutherford, Christine, Pavord, Ian D
Publicado 2023

Step 4: stick or twist? A review of asthma therapy

por Slater, Mariel G, Pavord, Ian D, Shaw, Dominick E
Publicado 2016

The assessment of quality of life in acute cough with the Leicester Cough Questionnaire (LCQ-acute)

por Yousaf, Nadia, Lee, Kai K, Jayaraman, Bhagyashree, Pavord, Ian D, Birring, Surinder S
Publicado 2011

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial

por Siva, Roshan, Bafadhel, Mona, Monteiro, William, Brightling, Christopher E, Pavord, Ian D
Publicado 2014

Exacerbations of COPD

por Pavord, Ian D, Jones, Paul W, Burgel, Pierre-Régis, Rabe, Klaus F
Publicado 2016

Asthma remission: what is it and how can it be achieved?

por Thomas, Dennis, McDonald, Vanessa M., Pavord, Ian D., Gibson, Peter G.
Publicado 2022

The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β(2)-agonists in the United Kingdom: a cross-sectional analysis

por Pavord, Ian D., Mathieson, Nicola, Scowcroft, Anna, Pedersini, Riccardo, Isherwood, Gina, Price, David
Publicado 2017

Author Correction: The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β(2)-agonists in the United Kingdom: a cross-sectio...

por Pavord, Ian D., Mathieson, Nicola, Scowcroft, Anna, Pedersini, Riccardo, Isherwood, Gina, Price, David
Publicado 2017

Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma

por Beasley, Richard, Harper, James, Bird, Grace, Maijers, Ingrid, Weatherall, Mark, Pavord, Ian D.
Publicado 2019

Sub‐stratification of type‐2 high airway disease for therapeutic decision‐making: A ‘bomb’ (blood eosinophils) meets ‘magnet’ (FeNO) framework

por Couillard, Simon, Pavord, Ian D., Heaney, Liam G., Petousi, Nayia, Hinks, Timothy S. C.
Publicado 2022

Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigm

por Blakey, John D, Woolnough, Kerry, Fellows, Jodie, Walker, Samantha, Thomas, Mike, Pavord, Ian D
Publicado 2013

Defining severe obstructive lung disease in the biologic era: an endotype-based approach

por Martin, Richard J., Bel, Elisabeth H., Pavord, Ian D., Price, David, Reddel, Helen K.
Publicado 2019

Asthma progression and mortality: the role of inhaled corticosteroids

por O'Byrne, Paul, Fabbri, Leonardo M., Pavord, Ian D., Papi, Alberto, Petruzzelli, Stefano, Lange, Peter
Publicado 2019

Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)

por Couillard, Simon, Do, William Il Hoon, Beasley, Richard, Hinks, Timothy S.C., Pavord, Ian D.
Publicado 2021

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population

por Ashdown, Helen F., Smith, Margaret, McFadden, Emily, Pavord, Ian D., Butler, Chris C., Bafadhel, Mona
Publicado 2021